Skip to main content
Global
Global Fin Swe Nor Den Ger Cze Svk Pol Hun Nld Bel (nl) Bel (fr) USA
Log in
  • Aidian – Your aid in diagnostics
  • Products
  • About us
  • News
  • Antimicrobial resistance
  • Aidian Academy
  • Customer stories
  • Events
  • For distributors / Log in
Contact us Search
Logo
Contact us
  • Point of care
  • Microbiology
  • Molecular diagnostics
  • Hygiene monitoring
  • RIA / Collagens
  • Respiratory tract infections
  • Products available in the USA
Point of care
  • QuikRead go system
  • QuikRead 101
Read more
QuikRead go
  • QuikRead go Plus Instrument
  • QuikRead go Instrument
  • QuikRead go easy CRP
  • QuikRead go CRP
  • QuikRead go CRP+Hb
  • QuikRead go wrCRP
  • QuikRead go wrCRP+Hb
  • QuikRead go HbA1c
  • QuikRead go Strep A
  • QuikRead go iFOBT
  • QuikRead go accessories
QuikRead go
Microbiology
  • Uricult
  • Uricult Vet
  • Cultura M
Read more
Molecular diagnostics
  • SIBA
Read more
SIBA licensing and partnering opportunities
Read more
Hygiene monitoring
  • Easicult
  • Hygicult
  • Clean Card PRO
Read more
NEW! A comprehensive guide to monitoring surface hygiene now published
Read more
RIA / Collagens
  • UniQ
Read more
  • Our history
  • Board and management
  • Sustainability
  • Culture
  • Careers
  • Employee stories
  • Partnering and licensing
  • UN Global Compact Commitment | Aidian
  • News
  • Product news
  • AMR
  • Events
  • Stories from customers
  • COVID-19
  • About C-reactive protein (CRP)
  • AMR interview
  • CRP and lower respiratory tract infections
  • Educational materials
  • QuikRead go CRP products
  • Spreading of antibiotic resistant bacteria
  • Useful links
  • Generally
  • Product information
  • Courses
  • Documents and materials
  • Frequently asked questions
  • Sleeping hygiene: monitoring cleanliness of pillows and bedding
Logo
Contact us Close
  • Products
    • Point of care
      • QuikRead go system
      • QuikRead 101
    • Microbiology
      • Uricult
      • Uricult Vet
      • Cultura M
    • Molecular diagnostics
      • SIBA
    • Hygiene monitoring
      • Easicult
      • Hygicult
      • Clean Card PRO
    • RIA / Collagens
      • UniQ
    • Respiratory tract infections
    • Products available in the USA
  • About us
    • Our history
    • Board and management
    • Sustainability
    • Culture
    • Careers
    • Employee stories
    • Partnering and licensing
    • UN Global Compact Commitment | Aidian
  • News
    • News
    • Product news
    • AMR
    • Events
    • Stories from customers
    • COVID-19
  • Antimicrobial resistance
    • About C-reactive protein (CRP)
    • AMR interview
    • CRP and lower respiratory tract infections
    • Educational materials
    • QuikRead go CRP products
    • Spreading of antibiotic resistant bacteria
    • Useful links
  • Aidian Academy
    • Generally
    • Product information
    • Courses
    • Documents and materials
    • Frequently asked questions
  • Customer stories
    • Sleeping hygiene: monitoring cleanliness of pillows and bedding
  • Events
  • For distributors / Log in
Popular products
QuikRead go Plus Instrument

QuikRead go Plus Instrument

QuikRead go HbA1c

QuikRead go HbA1c

SIBA

SIBA

Latest news
View all

May 5 is World Hand Hygiene Day

May 5, 2025 | News, Product news

Meet us at EuroMedLab 2025!

April 29, 2025 | Events

Are you prepared for tick season?

April 9, 2025 | News, Product news

  • View all
  • No results found
  • Loading...
News

May 5 is World Hand Hygiene Day

May 5, 2025 | News, Product news

Meet us at EuroMedLab 2025!

April 29, 2025 | Events

Homepage Point of care QuikRead go system QuikRead go iFOBT

QuikRead go iFOBT

QuikRead go iFOBT is an faecal immunochemical test (FIT) for the detection and quantitation of faecal haemoglobin (f-Hb) in stool samples. QuikRead go iFOBT is carried out with point of care Quikread go instrument. Depending on the settings, the instrument gives quantitative or qualitative results in less than 2 minutes with minimal hands-on time.

QuikRead go iFOBT kit box
  • Generally
  • Technical data
  • Additionally needed materials
  • Faecal occult blood (FOB) testing and colorectal cancer
  • Documents and materials
  • Videos

Generally

Efficient and objective feacal immunochemical testing with QuikRead go iFOBT

QuikRead go iFOBT is a point of care FIT test with an intuitive testing procedure on the Quikread go instrument. QuikRead go iFOBT detects haemoglobin originating from occult blood in human faeces in cases of excess bleeding from the lower gastrointestinal tract seen e.g. in ulcerative colitis, Crohn’s disease, adenomas and colorectal cancer (CRC). The test can be used in routine physical examinations, for symptomatic patients and in CRC screening.

QuikRead go iFOBT

Straightforward testing procedure

  • 5 days sample stability in the sampling tube at 18-25°C allows convenient at-home sampling and flexible return time of the sampling tube to the testing site
  • Handy and hygienic sampling vial regulates the quantity of the stool sample
  • Minimal hands-on time with only few manual steps

Accurate results for informed treatment decisions

  • Quantitative results: interpretation facilitation according to nationally recommended cut-off values
  • Results: consideration against each patient’s age, gender, or potential risk factors
  • f-Hb measuring range for quantitative tests: 10-200 µg/g in faeces or 50-1000 ng/ml in test solution
  • Instrument settings: selection allowance for a qualitative result with a cut-off of 15 µg/g (75 ng/ml)

Effortless testing with the QuikRead go multianalyte instrument

  • Ready-to-use reagents
  • Fully automated measurement
  • Maintenance free
  • Battery use ensures full portability
  • Bi-directional connectivity to most HIS and LIS systems

Test results should never be used alone, without a complete clinical evaluation.

QuikRead go iFOBT is not registered in the USA.

Technical data

Products available
  • 151051 QuikRead go iFOBT, 50 tests
UseFor in vitro diagnostic use, IVD CE
Method

Immunoturbidimetric

Sample typeFeces
Instrument information

QuikRead go system instruments

Measurement timeLess than 2 minutes
Reading of the resultInstrument read
Storage2 - 8 °C
Size and weight10 x 14 x 8 cm, 452 g
Additionally needed

With QuikRead go iFOBT 151051

  • QuikRead go Plus Instrument 155378 or QuikRead go Instrument 133893
  • QuikRead iFOB Sampling Set (50 sampling tubes) 151052
  • QuikRead FOB Positive Control 130054 (06027)
  • QuikRead go iFOBT Control Quantitative 152390

With QuikRead go iFOBT 136189

  • QuikRead go Plus Instrument 155378 or QuikRead go Instrument 133893
  • QuikRead FOB Sampling Set 138822
  • QuikRead FOB Positive Control 130054 (06027)
  • QuikRead FOB Control Quantitative 144675
Country of originFinland
RegistrationNot registered in the USA
Registered trademarkQuikRead go is a registered trademark of Aidian Oy

Additionally needed materials

QuikRead iFOB Sampling Set and QuikRead FOB Sampling Set contains 50 sampling tubes with buffer, instructions for use, patient labels and patient instructions. These tubes are designed to collect the defined feces amount into the buffer and to dispense the correct volume of sample solution into the test cuvette. The sampling tubes are intended for use with QuikRead go iFOBT or QuikRead FOB quantitative tests.

(image)

QuikRead FOB Positive Control is intended for high concentration quality control of QuikRead FOB quantitative and QuikRead go iFOBT assays. If the qualitative measurement is in use, the result should be “Positive” and when the test is used as quantitative, the result should be > 1000 ng/ml or > 200 µg/g

(image)

QuikRead go iFOBT Control Quantitative and QuikRead FOB Control Quantitative kits are intended for low concentration quality control of QuikRead FOB quantitative or QuikRead go iFOBT assays. The control should provide a “Positive” result when the qualitative measurement is used and when the quantitative measurement is used, the result should be within the range indicated on the control vial label.

(image)

Faecal occult blood (FOB) testing and colorectal cancer

Faecal occult blood can be a sign of colorectal cancer

Colorectal cancer (CRC) is a cancer of the colon, rectum, or anus. According to the World Health Organization (WHO), CRC is currently the third most common cancer and the second most common cancer-related cause of death worldwide. Around 1.9 million CRC cases are diagnosed annually.1

Many genetic and environmental factors and clinical conditions increase the risk for CRC. The development of CRC is slow, it usually takes 10-15 years, and it mainly affects individuals older than 50 years old. CRC usually begins with the growth of noncancerous cell clumps, called polyps, in the mucous membrane of the colon. Over time, some of these polyps and adenomas may turn into cancer.

Many people do not experience symptoms in the early stages of CRC. However, the blood vessels of colorectal polyps or cancers are often fragile and easily bleed into the colon or rectum. In healthy individuals, small quantities of lower gastrointestinal bleeding may occur, but it may also be a symptom of a gastrointestinal disorder. In addition to polyps, adenomas, and CRC tumours, other conditions, such as ulcerative colitis and Crohn’s disease, may cause bleeding in the lower intestine. This bleeding is rarely visible by the naked eye in the stool, but the hemoglobin of the faecal occult blood can be detected by the faecal immunochemical test (FIT), such as QuikRead go iFOBT.

Faecal immunochemical test levels correlate with the cancer severity

The faecal hemoglobin concentrations are generally higher in men than women and increase by age2. FIT levels also correlate with the cancer severity3. In symptomatic patients, point of care (POC) QuikRead go iFOBT provides quantitative information on excessive bleeding and aids in triaging patients for further gastrointestinal tract investigations, such as colonoscopy. Negative results assist in the identification of patients who would unlikely benefit from the colonic investigation, or they can be assigned for lower priority. Thus, negative iFOBT results may reduce unnecessary colonoscopies.4 A POC FIT allows immediate test results that can be used for faster decision making and improved risk-stratification of the patients.

Early detection of colorectal cancer improves the chance of survival

The early detection of CRC or its precursors significantly improves the chance for survival, requires less invasive treatment, and reduces treatment costs. Screening of people at moderate risk for CRC have been shown to reduce CRC mortality and incidence.5 Screening of CRC using FIT tests is recommended currently by the Council of Europe in the EU countries and by the American College of Physicians in the USA for individuals between 50-74 years old5,6.

Adjustable cut-off in colorectal screening

The quantitative FIT result enables adjustment of cut-offs according to the patient need or to meet recommendations in the national screening programs in the different countries. The optimal cut-off can be adjusted based on available endoscopic resources, CRC prevalence in the population, and expected participation rate in the screening program7. FIT cut-offs of 20-30 µg/g are recommended when the health care system can organize colonoscopies for approximately 5% of the screened (and FIT positive) patients aged 50-74 years8.

References

  1. World Health Organization. Global Cancer Observatory database. https://gco.iarc.fr/ Accessed 25.2.2022.
  2. McDonald PJ et al. Faecal hemoglobin concentration by gender and age; implications for population – based screening for colorectal cancer. Clin Chem Lab Med. 2012; 50:935-40.
  3. Navarro M et al. Fecal hemoglobin concentration, a good predictor of risk of advanced colorectal neoplasia in symptomatic and asymptomatic Patients. Front Med (Lausanne) 2019; 6:31.
  4. Mclean W et al. Diagnostic accuracy of point of care faecal immunochemical testing using a portable high-speed quantitative analyser for diagnosis in 2-week wait patients. Colorectal Disease 2021; 00:1–11.
  5. European commission. European guidelines for quality assurance in colorectal cancer screening and diagnosis – First Edition. Segnan N, Patrick J, von Karsa L (eds.), 2010, Luxenbourg.
  6. Rex D et al. Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol 2017; 112:1016-1030.
  7. Grazzini G et al. Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening? Br J Cancer 2009; 100:259-265.
  8. Hamza S et al. Diagnostic yield of a one sample immunochemical test at different cut-off values in an organised screening programme for colorectal cancer. Eur J Cancer 2013; 49:2727-2733.

Documents and materials

Marketing and sales materials

QuikRead go iFOBT Sales Sheet (EN)

QuikRead go iFOBT Brief Instruction (EN)

QuikRead go Plus Family Brochure (EN)

QuikRead go Family Brochure (EN)

QuikRead go Technical Specifications (EN)

QuikRead go Plus Technical Specifications (EN)

Immunochemical Faecal Occult Blood tests (EN)

QuikRead go iFOB Sampling set ePoster Labquality Days 2018 (EN)

QuikRead go Control Information (EN)

QuikRead go workstation Flyer (EN)

Instructions for use

(For informative use only. Kindly always refer to the latest package insert in the kit.)

QuikRead go iFOBT IFU (GB, DE, FR, EE) 151051

QuikRead go iFOBT IFU (FI, SE, NO, DK) 151051

QuikRead go iFOBT IFU (CZ, SK, ES, NL) 151051

QuikRead iFOB Sampling Set IFU (GB, DE, FR, NL, ES, EE, CZ, PL, SK, SE, NO, FI, DK) 151052

QuikRead iFOB Sampling Set Patient IFU, 151052

QuikRead FOB Positive Control IFU (GB, DE, FR, NL, ES, IT, CZ, SK, HU, PL, SI, SE, NO, DK, FI), 06027

QuikRead go iFOBT Control Quantitative (GB, FR, DE, NL, ES, IT, SK, CZ, EE, SI, PL, SE, DK, NO, FI), 152390

Revision history QuikRead iFOB Sampling Set (GB, DE, FR, ES, NL, EE, CZ, SK, PL, SE, NO, DK, FI), 151052

Safety Data Sheet

If you wish to receive a Safety data sheet, please contact: product.support@aidian.eu

Videos

  • Test videos using QuikRead go Instrument
  • Test videos using QuikRead go Plus Instrument

Interested in these products? Please contact

  • Head office
  • Contact in your country

Aidian Oy

Koivu-Mankkaan tie 6 B,
FI-02200 Espoo,
Finland

P.O. Box 83,
FI-02101 Espoo,
Finland

+358 10 309 3000
Company
  • About us
  • Careers
  • Contact us
  • Events
  • Product-specific inquiries
  • Sales support
  • Sales related inquiries
  • Sustainability
Products
  • Point of care
  • Microbiology
  • Molecular diagnostics
  • Hygiene monitoring
  • RIA / Collagens
  • Respiratory tract infections
Quick links
  • Aidian Academy
  • Aidian Connect
  • IFU Revision histories
Copyright © 2025 Aidian
  • Privacy Policy
  • Privacy Statements
  • Cookie Policy
  • Social Media Policy